Self-medication during the Era of COVID-19; Potential Implications for Drug Policy Makers and Pharmacovigilance
Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net..
The Coronavirus disease (COVID-19) outbreak is marked by infodemic amid conspiracy theories, false claims, rumors, and misleading narratives, which have had a significant impact on the global campaign against COVID-19. The drug repurposing provides a hope to curb the growing encumbrance of the disease but at the same time, it poses various challenges such as selfmedication using repurposed drugs and its associated harms. During the continuing pandemic, this perspective piece explores the potential hazards of self-medication and its attributing factors along with possible countermeasures.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:18 |
|---|---|
| Enthalten in: |
Current drug safety - 18(2023), 2 vom: 10., Seite 122-124 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Mallhi, Tauqeer Hussain [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Adverse effects |
|---|
| Anmerkungen: |
Date Completed 09.03.2023 Date Revised 09.03.2023 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.2174/1574886317666220428133813 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM35389026X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM35389026X | ||
| 003 | DE-627 | ||
| 005 | 20231226061039.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2174/1574886317666220428133813 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1179.xml |
| 035 | |a (DE-627)NLM35389026X | ||
| 035 | |a (NLM)36883267 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Mallhi, Tauqeer Hussain |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Self-medication during the Era of COVID-19; Potential Implications for Drug Policy Makers and Pharmacovigilance |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 09.03.2023 | ||
| 500 | |a Date Revised 09.03.2023 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net. | ||
| 520 | |a The Coronavirus disease (COVID-19) outbreak is marked by infodemic amid conspiracy theories, false claims, rumors, and misleading narratives, which have had a significant impact on the global campaign against COVID-19. The drug repurposing provides a hope to curb the growing encumbrance of the disease but at the same time, it poses various challenges such as selfmedication using repurposed drugs and its associated harms. During the continuing pandemic, this perspective piece explores the potential hazards of self-medication and its attributing factors along with possible countermeasures | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a adverse effects | |
| 650 | 4 | |a conspiracy theories | |
| 650 | 4 | |a drug repurposing | |
| 650 | 4 | |a safety profile | |
| 650 | 4 | |a self-medication | |
| 700 | 1 | |a Khan, Yusra Habib |e verfasserin |4 aut | |
| 700 | 1 | |a Butt, Muhammad Hammad |e verfasserin |4 aut | |
| 700 | 1 | |a Salman, Muhammad |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Current drug safety |d 2006 |g 18(2023), 2 vom: 10., Seite 122-124 |w (DE-627)NLM181475790 |x 2212-3911 |7 nnns |
| 773 | 1 | 8 | |g volume:18 |g year:2023 |g number:2 |g day:10 |g pages:122-124 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.2174/1574886317666220428133813 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 18 |j 2023 |e 2 |b 10 |h 122-124 | ||